These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 3137252

  • 1. The influence of diabetes mellitus on thyrotropin response to thyrotropin-releasing hormone in untreated acromegalic patients.
    Shigemasa C, Abe K, Taniguchi S, Mitani Y, Ueta Y, Adachi T, Urabe K, Tanaka T, Yoshida A, Hori T.
    J Endocrinol Invest; 1988 Apr; 11(4):231-7. PubMed ID: 3137252
    [Abstract] [Full Text] [Related]

  • 2. The pituitary-thyroid axis in acromegaly.
    Eskildsen PC, Kruse A, Kirkegaard C.
    Horm Metab Res; 1988 Dec; 20(12):755-7. PubMed ID: 3146541
    [Abstract] [Full Text] [Related]

  • 3. Impaired pituitary thyrotroph function in uncontrolled type II diabetes mellitus: normalization on recovery.
    Kabadi UM.
    J Clin Endocrinol Metab; 1984 Sep; 59(3):521-5. PubMed ID: 6430948
    [Abstract] [Full Text] [Related]

  • 4. Normalization of thyroid stimulating hormone levels in acromegalic patients after selective adenomectomy.
    Tsuchiya H, Onishi T, Mori S, Lee S, Kohno H, Imanaka S, Saitoh Y, Mogami H, Uozumi T, Kumahara Y.
    Endocrinol Jpn; 1984 Dec; 31(6):687-95. PubMed ID: 6442697
    [Abstract] [Full Text] [Related]

  • 5. Hypothalamic-pituitary-thyroid axis in acromegaly.
    Carmina E, Rosato F, Pirronello S, Jannì A.
    J Endocrinol Invest; 1983 Aug; 6(4):263-6. PubMed ID: 6417217
    [Abstract] [Full Text] [Related]

  • 6. Preserved thyroidal secretion of thyroxine in acromegalic patients with suppressed hypophyseal secretion of thyrotrophin.
    Yoshinari M, Tokuyama T, Kuroda T, Sato K, Okazawa K, Mizokami T, Okamura K, Fujishima M.
    Clin Endocrinol (Oxf); 1992 Apr; 36(4):355-60. PubMed ID: 1424168
    [Abstract] [Full Text] [Related]

  • 7. [The relationship between TSH response to TRH and GH response to dopaminergic agents in patients with acromegaly].
    Tokuyama T, Yoshinari M, Okamura K, Ikenoue H, Sato K, Kuroda T, Fujishima M.
    Nihon Naibunpi Gakkai Zasshi; 1991 Feb 20; 67(2):65-74. PubMed ID: 1674920
    [Abstract] [Full Text] [Related]

  • 8. Oral thyrotropin-releasing hormone (TRH) test in acromegaly.
    Marek J, Límanová Z, Srámková J.
    Endokrinologie; 1981 Oct 20; 78(1):57-66. PubMed ID: 6797816
    [Abstract] [Full Text] [Related]

  • 9. Serum thyrotropin and prolactin in the syndrome of generalized resistance to thyroid hormone: responses to thyrotropin-releasing hormone stimulation and short term triiodothyronine suppression.
    Sarne DH, Sobieszczyk S, Ain KB, Refetoff S.
    J Clin Endocrinol Metab; 1990 May 20; 70(5):1305-11. PubMed ID: 2110573
    [Abstract] [Full Text] [Related]

  • 10. The pituitary-thyroid axis in patients with pituitary disorders.
    Eskildsen PC, Kruse A, Kirkegaard C.
    Horm Metab Res; 1989 Jul 20; 21(7):387-90. PubMed ID: 2506120
    [Abstract] [Full Text] [Related]

  • 11. Effects of acute infusion of erythropoietin on paradoxical responses of growth hormone to thyrotropin-releasing hormone in acromegalic patients.
    Díez JJ, Iglesias P, Sastre J, Gómez-Pan A.
    Eur J Endocrinol; 2000 Aug 20; 143(2):203-11. PubMed ID: 10913939
    [Abstract] [Full Text] [Related]

  • 12. Human prolactin and thyrotropin concentrations in the serums of normal and hypopituitary children before and after the administration of synthetic thyrotropin-releasing hormone.
    Foley TP, Jacobs LS, Hoffman W, Daughaday WH, Blizzard RM.
    J Clin Invest; 1972 Aug 20; 51(8):2143-50. PubMed ID: 4626583
    [Abstract] [Full Text] [Related]

  • 13. Effects of repetitive administration of thyrotropin-releasing hormone at short intervals in acromegaly.
    Losa M, Alba-Roth J, Sobieszczyk S, Schopohl J, Müller OA, von Werder K.
    Acta Endocrinol (Copenh); 1989 Mar 20; 120(3):383-9. PubMed ID: 2494827
    [Abstract] [Full Text] [Related]

  • 14. Thyrotropin and prolactin secretory patterns during 24-hours infusion of thyrotropin-releasing hormone in calves.
    Ohlson DL, Davis SL, Anfinson MS, Klindt J.
    Neuroendocrinology; 1978 Mar 20; 26(3):163-73. PubMed ID: 98724
    [Abstract] [Full Text] [Related]

  • 15. Prolactin secretion in acromegalic patients before and after selective adenomectomy.
    Tsuchiya H, Onishi T, Takamoto S, Imanaka S, Saitoh Y, Mogami H, Mori S, Uozumi T, Kumahara Y.
    J Clin Endocrinol Metab; 1985 Jul 20; 61(1):104-9. PubMed ID: 3923026
    [Abstract] [Full Text] [Related]

  • 16. Induction of hypothyroidism and hypoprolactinemia by growth hormone producing rat pituitary tumors.
    Seo H, Refetoff S, Fang VS.
    Endocrinology; 1977 Jan 20; 100(1):216-26. PubMed ID: 401484
    [Abstract] [Full Text] [Related]

  • 17. Familial hyperthyroidism due to inappropriate thyrotropin secretion successfully treated with triiodothyronine.
    Rösler A, Litvin Y, Hage C, Gross J, Cerasi E.
    J Clin Endocrinol Metab; 1982 Jan 20; 54(1):76-82. PubMed ID: 6798060
    [Abstract] [Full Text] [Related]

  • 18. Sustained rises in serum thyrotropin, thyroxine, and triiodothyronine during long term, continuous thyrotropin-releasing hormone treatment in patients with amyotrophic lateral sclerosis.
    Kaplan MM, Taft JA, Reichlin S, Munsat TL.
    J Clin Endocrinol Metab; 1986 Oct 20; 63(4):808-14. PubMed ID: 3091628
    [Abstract] [Full Text] [Related]

  • 19. Serum prolactin and growth hormone response to thyrotropin-releasing hormone in patients with pituitary adenomas.
    Chang CC, Chen FW, Hsieh HC.
    Taiwan Yi Xue Hui Za Zhi; 1989 May 20; 88(5):443-9. PubMed ID: 2507734
    [Abstract] [Full Text] [Related]

  • 20. Serum thyrotropin response to combined arginine and thyrotropin-releasing hormone administration provides evidence for an altered somatostatinergic tone in acromegaly.
    Merola B, Colao A, Cataldi M, Rossi E, Longobardi S, Caruso E, Lombardi G.
    Horm Res; 1992 May 20; 37(1-2):7-13. PubMed ID: 1356902
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.